Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Engine Capital, L.P. OFIX Orthofix Medical Inc. 13D/A 8.4% 2y
Karpus Management, Inc. NRK Nuveen New York Amt-Free Quality Municipal Income Fund 13D/A 23.37% 2y
GAMCO INVESTORS, INC. ET AL KAMN Kaman Corp 13D/A 0% 2y
Davidson Kempner Capital Management LP VCSA Vacasa, Inc. Class A Common Stock 13D 9.43% 2y
Millennium Management LLC SCRM Screaming Eagle Acquisition Corp. Class A Ordinary Shares 13G 8.5% 2y
Monte M. Brem STEP StepStone Group Inc. 13D/A 48% 2y
STEEL PARTNERS HOLDINGS L.P. STCN Steel Connect, Inc. Common Stock 13D/A 87.6% 2y
Deep Track Capital, LP ZURA Zura Bio Ltd 13G/A 9.34% 2y
Leviticus Partners LP TWIN Twin Disc Inc 13G/A 4.96% 2y
Encompass Capital Advisors LLC TE T1 Energy Inc. 13D 9.9% 2y
SB Value Partners, L.P. ASRV Ameriserv Financial Inc 13D 7.7% 2y
ICAHN CARL C IEP Icahn Enterprises L.P. 13D/A 86.32% 2y
Famatown Finance Ltd. INSW International Seaways, Inc. 13D/A 16.89% 2y
Standard General L.P. MDIA Mediaco Holding Inc. 13D/A 91.88% 2y
BB Biotech AG ANNX Annexon, Inc. 13G 5.2% 2y
Galkin Vladimir JBLU Jetblue Airways Corp 13G 5.3% 2y
BOXER CAPITAL, LLC IPSC Century Therapeutics, Inc. 13G 5.8% 2y
Larry A. Mizel MDC M.D.C. Holdings, Inc. 13D/A 0% 2y
David D. Mandarich MDC M.D.C. Holdings, Inc. 13D/A 0% 2y
Cove Street Capital, LLC TBRG TruBridge, Inc. 13G/A 4.86% 2y
GAMCO INVESTORS, INC. ET AL BBGI Beasley Broadcast Group Inc 13D/A 5.32% 2y
Iole Lucchese SCHL Scholastic Corp 13D 4.3% 2y
TANG CAPITAL MANAGEMENT, LLC MRNS Marinus Pharmaceuticals, Inc 13G 8.2% 2y
GAMCO INVESTORS, INC. ET AL TAST Carrols Restaurant Group, Inc. 13D 3.27% 2y
GAMCO INVESTORS, INC. ET AL LEE LEE ENTERPRISES, Inc 13D 2.76% 2y
NEWCASTLE PARTNERS, L.P. WHLM Wilhelmina International, Inc. 13D/A 47.1% 2y
Cuizhang Gong GDHG Golden Heaven Group Holdings Ltd. 13D 19.3% 2y
Impactive Capital LP VAC MARRIOTT VACATIONS WORLDWIDE Corp 13D 7.4% 2y
Nathan D. Hukill TTOO T2 Biosystems, Inc 13D 46.68% 2y
Commodore Capital LP CATX Perspective Therapeutics, Inc. 13G 6.6% 2y
TCG Crossover GP I, LLC ABVX Abivax S.A. 13G 9.6% 2y
Millennium Management LLC SLRN ACELYRIN, INC. Common Stock 13G 4.99% 2y
Stonepine Capital Management, LLC SRZN Surrozen, Inc. 13G 6% 2y
Greenhill Capital Partners III, L.P. ZETA Zeta Global Holdings Corp. 13G/A 2.35% 2y
Laurence E. Hirsch MDAI Spectral AI, Inc. 13G/A 5.15% 2y
Starboard Value LP AQN Algonquin Power & Utilities Corp. 13D/A 9% 2y
D.R. Horton, Inc. FOR Forestar Group Inc. 13D/A 62.2% 2y
180 Degree Capital Corp. SCOR Comscore, Inc. 13D/A 8.7% 2y
Skorpios Trust STOK Stoke Therapeutics, Inc. 13D/A 23.4% 2y
Erik B. Nordstrom JWN Nordstrom, Inc. 13D 7.45% 2y
ETFS Capital Limited. WT WisdomTree, Inc. 13D/A 10% 2y
Mithaq Capital SPC PLCE Childrens Place, Inc. 13D/A 56.1% 2y
Headlands Capital Management, LLC NDLS NOODLES & Co 13D/A 7.7% 2y
STEEL PARTNERS HOLDINGS L.P. STCN Steel Connect, Inc. Common Stock 13D/A 85.2% 2y
BAKER BROS. ADVISORS LP BCYC Bicycle Therapeutics PLC 13D 19.9% 2y
Gerard Barron TMC TMC the metals Co Inc. 13D/A 6.53% 2y
Saba Capital Management, L.P. SBI Western Asset Intermediate Muni Fund Inc. 13D/A 6.22% 2y
Klaus Umek CRTO Criteo S.A. 13D/A 6.41% 2y
Casdin Capital, LLC IPSC Century Therapeutics, Inc. 13G 6.08% 2y
Radoff Bradley Louis SYBX Synlogic, Inc. 13G 5.4% 2y